Jeil Pharmaceutical Co.,Ltd

KRX:271980.KS

15180 (KRW) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

202320222021202020192018201720162015
Assets:
Current Assets:
Cash & Cash Equivalents 32,990.88631,446.23425,963.2793,893.47413,515.2712,495.3416,208.24230,078.66313,538.06
Short Term Investments 2,666.657142.4582,040.0622,694.5884.76235003,093.0313,049.06
Cash and Short Term Investments 35,657.54331,588.69228,003.3416,588.06213,520.0332,845.3416,208.24233,171.69416,587.12
Net Receivables 166,225.495156,369.809148,995.065157,322.929162,325.271182,064.555198,701.454196,716.87198,160.584
Inventory 109,768.04599,150.809102,457.666109,310.61984,071.45288,446.06683,692.88680,452.4773,623.242
Other Current Assets 5,394.8394,531.4775,216.2544,291.2084,217.4380.0010.0012,408.772823.22
Total Current Assets 317,045.923291,640.788284,672.326277,512.818264,134.194273,355.962298,602.582312,749.806289,194.166
Non-Current Assets:
Property, Plant & Equipment, Net 137,040.757138,402.417125,709.643115,547.198121,614.302120,481.184102,658.484115,159.75492,082.516
Goodwill 000000000
Intangible Assets 12,880.9719,381.7513,762.3384,095.3694,323.8944,359.0534,090.26900
Goodwill and Intangible Assets 12,880.9719,381.7513,762.3384,095.3694,323.8944,359.0534,090.26900
Long Term Investments 11,725.6599,250.7562,992.114-774.939923.937627.9483,025.0457,415.59656,364.278
Tax Assets 5,359.488172.3871,451.5053,321.2512,359.711944.3922,005.39400
Other Non-Current Assets 3,273.58,043.4417,898.4929,961.6018,229.0823,134.5833,344.3336,659.8417,525.146
Total Non-Current Assets 170,280.375165,250.752141,814.092132,150.48137,450.925129,547.161115,123.52179,235.191155,971.94
Total Assets 487,326.298456,891.539426,486.418409,663.297401,585.119402,903.123413,726.102491,984.997445,166.106
Liabilities & Equity:
Current Liabilities:
Account Payables 144,338.12151,641.431153,084.038143,363.086149,575.963144,752.774146,726.744140,161.244129,398.469
Short Term Debt 80,513.60844,908.0232,205.79838,141.81314,005.96317,973.33336,314.62829,457.79721,345.475
Tax Payables 448.2451,049.118114.5693,432.2994,244.5491,359.6562,080.0712,647.0934,839.684
Deferred Revenue 1,733.8181,650.24221,355.61423,440.14332,260.5681,359.65623,415.585678.34331.751
Other Current Liabilities 91,584.91170,457.44515,297.73213,113.22812,676.78430,470.334-023,256.95823,954.287
Total Current Liabilities 318,170.458268,657.137221,943.181218,058.27208,519.278194,556.097206,456.956193,554.339175,029.982
Non-Current Liabilities:
Long Term Debt 4,452.0045,442.5688,148.62211,162.51518,417.64419,906.2525,50027,5005,000
Deferred Revenue Non-Current 200.011227.111248.111379.419346.111257.1110-00
Deferred Tax Liabilities Non-Current -200.011028,799.3057,583.8054,257.8023,249.1206,305.3487,285.499
Other Non-Current Liabilities 7,671.66426,967.5030.0010.001-0-03,782.90912,545.58116,462.17
Total Non-Current Liabilities 12,123.66832,637.18237,196.03919,125.7423,021.55723,412.48129,282.90946,350.92928,747.669
Total Liabilities 330,294.126301,294.32259,139.22237,184.01231,540.836217,968.578235,739.865239,905.268203,777.651
Equity:
Preferred Stock 13,795.33500000000
Common Stock 7,352.4367,352.4367,352.4367,352.4367,352.4367,352.4365,252.2477,4257,425
Retained Earnings -20,193.116-20,320.91-10,413.5542,840.8085,216.06618,850.5571,751.92227,629.913221,628.282
Accumulated Other Comprehensive Income/Loss 20,943.27920,870.42120,775.62116,969.53217,035.249,928.224020,103.91820,414.129
Other Total Stockholders Equity 136,672.186150,007.074150,498.857145,231.468140,440.543148,803.328170,982.071-6,218.277-8,078.956
Total Shareholders Equity 158,570.12157,909.021168,213.36172,394.244170,044.284184,934.545177,986.237248,940.553241,388.455
Total Equity 157,032.172155,597.22167,347.198172,479.288170,044.284184,934.545177,986.237252,079.729241,388.455
Total Liabilities & Shareholders Equity 487,326.298456,891.539426,486.418409,663.297401,585.119402,903.123413,726.102491,984.997445,166.106